Cloud-led Future · Intelligence-driven Hotline +86 21 6228 0217 中文 | EN

C-ROSS Phase II Fully Lands; 23 Insurers Raise 80B Yuan to Replenish Capital

Overview

From 2026, the transition period for “C-ROSS” Phase II ends and stricter capital and risk-measurement rules fully apply, with unlisted insurers concurrently adopting new financial-instrument and insurance-contract standards, Xinhua Finance reports. To meet rigidified capital constraints, 23 insurers have this year densely replenished capital via shareholder capital increases and strategic investors; another 19 insurers completed or won approval for 21 bond issues totalling ~60 billion yuan, of which 39 billion (nearly 70%) are perpetual bonds, surpassing traditional capital-supplement bonds in scale for the first time. Separately, the 2026 Financial Street Forum (October 19–22) will see the regulator host its first insurance conference, focused on tech, pension, inclusive and catastrophe insurance.

Background & Interpretation

1. Regulatory and Industry Context

Late-2021 rules set a “one-firm-one-policy” transition extended to end-2025. After it ends, capital constraints rigidify and minimum-capital requirements rise across the board — industry minimum capital up 5%–8% on average, with P&C up ~7.5% on higher non-auto risk weights. New accounting standards re-discount reserves at spot rates, and low rates raise reserve present value, further hitting net assets.

2. Core Drivers and Mechanisms

The wave of capital replenishment stems from the “C-ROSS II + new standards” double pressure: stricter measurement lifts minimum capital while new standards amplify rate-down erosion of net assets. Perpetual bonds, countable as core capital with flexible tenor, became the tool of choice; MoF special-bond capital injections into insurance SOEs and smaller insurers’ equity raises form a multi-tier system. At H1 end, average comprehensive solvency was 180.6% and core 133.5%, yet some smaller insurers still hover near the red line.

3. Market Structure and Industry Impact

A richer capital toolkit eases the sector’s “capital shortage” anxiety but means more profit funds future capital. For investors, solvency strength diverges — leaders consolidate via injections and bonds while laggards face rectification. The inaugural insurance conference offers a top-level platform for policy and product innovation across the four themes.

Implications & Outlook

Watch the continuing new-standard hit to net assets under low rates, perpetual-bond cost after supply ramps, and policy signals from the four insurance forums. The sector shifts from “scale race” to “capital and value in balance”.

Takeaways for Industry Participants

Insurers should plan capital replenishment ahead and optimise business mix to cut minimum-capital occupancy; investors can favour well-capitalised, high-value-margin names; bancassurance and broker channels must align with the product transition away from banned short-term products.

This column compiles industry information and shares technical perspectives; it does not constitute investment advice.